HAYWHayward Holdings, Inc.

$11.34-24% 1Y
Latest close: a new 52-week lowOct 9, 2026what changed →

Is the business good?

Mixed

The checks split: 7 of 9 health tests passed and margins widening, but thin cash backing (0.6×).

2 good, 1 to watch, 1 neutral
Fundamental health (F-score)7 / 9SEC EDGAR · Dec 31, 2025

High fundamental quality. Nine pass/fail tests of year-over-year health from the filings.

Profits arrive as cash0.56×derived · Mar 28, 2026

Operating profit outpaces operating cash flow, watch accruals and working capital. Conversion is worsening vs a year ago.

Margin direction, 3 years+3.2 pts

Positive operating leverage, operating profit is growing faster than sales, so margins widen as the business scales.

Where ROE comes from5% ROA

A balanced mix of margins, efficiency, and leverage. ROE 9% = margin × turnover × leverage.

Unless marked, from derived.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF conversionbehind 82% of the market
Leverage (Debt/EBITDA)middle of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is HAYW?

Hayward Holdings, Inc. earns 8.2% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.

8.2%

Return on invested capital · cost of capital 9.0% · 0.80 points below what the capital costs: growth destroys value

Operating margin
21%

Operating margin · Electrical Equipment & Parts median 6.7% · 12 months to Q1 2026

Cash conversion
0.56×

Cash conversion · 1.63× a year ago · the operating profit has not turned into cash yet

Share count, year on year
+0.26%

Share count, year on year · flat: no meaningful dilution

Operating margin by fiscal year
YearOperating margin
FY202014%
FY202123%
FY202222%
FY202318%
FY202420%
FY202521%
Details›
Gross margin12 months to Q1 2026
46%
Operating margin12 months to Q1 2026
21%
Net margin12 months to Q1 2026
14%
Free cash flow margin
7.0%
R&D as % of revenue
2.4%
Revenue, trailing twelve months
$1.15B
Free cash flow, trailing twelve months
$81M
Net income, trailing twelve months
$161M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
8.2%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.